Skip Navigation

Cardiovascular Research 1990 24(5):404-410; doi:10.1093/cvr/24.5.404
© 1990 by European Society of Cardiology
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hicks, M N
Right arrow Articles by Cobbe, S M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hicks, M N
Right arrow Articles by Cobbe, S M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1990, European Society of Cardiology

Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.l-sotalol and d-sotalol

M N Hicks and S M Cobbe

Department of Medical Cardiology, Royal Infirmary, 10 Alexandra Parade, Glasgow G31 2ER, United Kingdom

Study objective – The aim was to study the effects of d.l-sotalol, d-sotalol or atenolol on the rate of rise of extracellular potassium concentration ([K-]o) and the electrophysiological changes that occur during myocardial ischaemia.

Design – The study was performed in isolated, arterially perfused interventricular septa from rabbit. Six septa were treated with d.l-sotalol 10–4mol·litre–1, six with d-sotalol 10–4 mol·litre–1, six with atenolol 10–5 mol·litre–1, and there were seven untreated controls. At these concentrations d.l and d-sotalol are equipotent in their class III effect, though d-sotalol has only 7% of the β blocking activity of the racemic form, and atenolol is equipotent in its β blocking activity to d.l-sotalol. [K-]o and electrophysiological variables were compared before and during a 30 min period of global zero flow ischaemia.

Measurements and main results – Prior to ischaemia [K-]o, measured using potassium sensitive valinomycin electrodes, was similar in all the groups. [K-]o rose during ischaemia in all the groups, and at 30 min was 13.0 (SEM 0.7) mmol·litre–1 in the control group which was not different from 12.7(0.5) mol·litre–1 in the atenolol group. In the d.l and d-sotalol groups the increases were markedly attenuated, reaching 9.2(1.0) and 8.8(0.7) mmol·litre–1 respectively. During ischaemia the class III effect of d.l and d-sotalol was lost within 6 min though the fall in maximum upstroke velocity of the action potentials (dV/dtmax) and the extent of resting membrane potential (Em) depolarisation were less in comparison to the control and atenolol groups.

Conclusions – The results indicate an attenuation by sotalol of the ischaemic rise in [K-]o, with preservation of dV/dtmax and Em, despite the loss of an effect on action potential duration. This potentially antiarrhythmic effect of sotalol in ischaemic myocardium is attributable to a direct membrane effect rather than p adrenoceptor antagonism.

KEYWORDS ischaemia; extracellular potassium; class III effect; sotalol

Correspondence to: Dr Hicks


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 CirculationHome page
A. Kanda, I. Watanabe, M. L. Williams, C. L. Engle, S. Li, G. G. Koch, and L. S. Gettes
Unanticipated Lessening of the Rise in Extracellular Potassium During Ischemia by Pinacidil
Circulation, April 1, 1997; 95(7): 1937 - 1944.
[Abstract] [Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.